DNAPrint Genomics (DNAG) Financial Statements
DNAPrint Genomics Financial Overview
DNAPrint Genomics's market cap is currently $1.29K. The company's EPS TTM is ―; its P/E ratio is 0.00; DNAPrint Genomics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 06 | Dec 05 | Dec 04 | Dec 03 | Dec 02 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 754.07K | $ 325.03K | $ 277.70K | $ 277.41K | $ 111.35K |
| Operating Income | $ -8.87M | $ -4.66M | $ -3.33M | $ -6.23M | $ -2.61M |
| EBITDA | $ -6.05M | $ -2.38M | $ -2.28M | $ -5.19M | $ -2.16M |
| Net Income | $ -12.35M | $ -8.72M | $ -3.73M | $ -7.79M | $ -3.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 10.27M | $ 6.31M | $ 1.79M | $ 1.29M | $ 422.73K |
| Total Debt | $ 7.28M | $ 1.07M | $ 628.47K | $ 833.27K | $ 867.76K |
| Net Debt | $ -1.21M | $ -736.73K | $ -350.06K | $ 567.35K | $ 855.98K |
| Total Liabilities | $ 13.98M | $ 10.40M | $ 1.70M | $ 3.33M | $ 1.53M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -6.17M | $ -3.73M | $ -3.82M | $ -1.54M | $ -1.59M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD